Dr. Cathleen M. McCabe, MD

Dr. McCabe practices at The Eye Associates Surgery Center Bradenton in Bradenton, Florida.

Dr. McCabe's NPI, 1700840493, was assigned on April 12, 2006. Dr. McCabe graduated from Medical College Of Wisconsin in 1996. Dr. McCabe holds Florida license ME82170.

Dr. McCabe's primary practice is The Eye Associates Surgery Center Bradenton, at 6002 Pointe West Blvd, Bradenton, FL 34209. The practice phone is (813) 792-2020.

Dr. McCabe's primary practice is The Eye Associates Surgery Center Bradenton in Bradenton, Florida. Dmand AI also links Dr. McCabe to 1 medical group, named with a free account. Dr. McCabe's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCabe practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. McCabe's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. McCabe is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. McCabe's licenses on file in 5 states: Florida, Texas, Indiana, Michigan and Ohio.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, eye infection or inflammation, glaucoma, glaucoma surgery, hereditary corneal conditions and secondary membranaous cataract surgery among the conditions Dr. McCabe treats.

CMS data shows 1,974 Medicare services from Dr. McCabe across 12 procedure codes in 2024, for 511 Medicare patients. Medicare paid $278,682 for them.

CMS counts 511 Medicare patients who saw Dr. McCabe in 2024. The largest group is 65 to 74, with 251 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McCabe's median patient age at 76, with 61% women.

In 2024, Dr. McCabe wrote 491 Medicare Part D claims for 167 patients. 39% of them were for generic drugs. CMS names the drug for 394 of them, across 13 drugs with 11 or more claims each, at $147,597 in total drug cost. In 2023, CMS named 1,077 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. McCabe for performance year 2024, reported as part of a group. Dr. McCabe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 423 procedures of cataract surgery by Dr. McCabe, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. McCabe, published from 2019 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Visual Acuity, Fundus Oculi and Intraocular Pressure. Dr. McCabe has published most often in Arch Ophthalmol. Dr. McCabe's most frequent co-authors are Harry W. Flynn, MD, Preeya Kshettry Gupta, MD and John Palmer Berdahl, MD.

Dmand AI links Dr. McCabe to 2 clinical trials. Conditions studied include Choroidal Effusions, Dry Eye Syndromes and Eye Abnormalities. Open Payments lists research payments to Dr. McCabe that name 1 trial.

CMS Open Payments shows 1,814 general payments to Dr. McCabe from 49 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Bausch & Lomb Americas Inc. paid the most, $1,196,316. It also lists 4 research payments totaling $10,404 from 2016 to 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. McCabe.

Dr. McCabe graduated from Medical College Of Wisconsin in 1996. Dr. McCabe is a member of AAO and ASCRS.

Dr. McCabe is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and Aetna. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.